Compare DKNG & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DKNG | BAX |
|---|---|---|
| Founded | 2011 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 10.2B |
| IPO Year | 2021 | 1994 |
| Metric | DKNG | BAX |
|---|---|---|
| Price | $22.88 | $18.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 31 | 9 |
| Target Price | ★ $39.13 | $21.00 |
| AVG Volume (30 Days) | ★ 12.3M | 6.7M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.21% |
| EPS Growth | ★ 99.05 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,054,525,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $15.47 | $1.96 |
| Revenue Next Year | $13.09 | $2.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 26.99 | 5.72 |
| 52 Week Low | $20.46 | $15.73 |
| 52 Week High | $48.78 | $32.68 |
| Indicator | DKNG | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 63.66 |
| Support Level | $21.06 | $18.61 |
| Resistance Level | $24.05 | $19.82 |
| Average True Range (ATR) | 0.93 | 0.55 |
| MACD | 0.18 | 0.33 |
| Stochastic Oscillator | 54.40 | 90.28 |
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number-two or -three revenue share position across states where it competes. DraftKings is now live with online or retail sports betting in 28 states and i-gaming in 5 states, with both products available to around 40% of Canada's population. In 2024, sports revenue was 61% of total sales, i-gaming 32%, and fantasy and lottery 7%. The company plans to launch a predictive event platform in late 2025 and also operates a non-fungible token commission-based marketplace and develops and licenses online gaming products.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.